全文获取类型
收费全文 | 110873篇 |
免费 | 7359篇 |
国内免费 | 762篇 |
专业分类
耳鼻咽喉 | 1263篇 |
儿科学 | 3364篇 |
妇产科学 | 2798篇 |
基础医学 | 15166篇 |
口腔科学 | 2449篇 |
临床医学 | 9592篇 |
内科学 | 23866篇 |
皮肤病学 | 2274篇 |
神经病学 | 10577篇 |
特种医学 | 4224篇 |
外国民族医学 | 23篇 |
外科学 | 14767篇 |
综合类 | 1796篇 |
现状与发展 | 1篇 |
一般理论 | 68篇 |
预防医学 | 7335篇 |
眼科学 | 1748篇 |
药学 | 9042篇 |
3篇 | |
中国医学 | 564篇 |
肿瘤学 | 8074篇 |
出版年
2023年 | 620篇 |
2022年 | 1297篇 |
2021年 | 2340篇 |
2020年 | 1548篇 |
2019年 | 2260篇 |
2018年 | 2636篇 |
2017年 | 2035篇 |
2016年 | 2092篇 |
2015年 | 2406篇 |
2014年 | 3162篇 |
2013年 | 4534篇 |
2012年 | 6292篇 |
2011年 | 6378篇 |
2010年 | 3963篇 |
2009年 | 3526篇 |
2008年 | 5498篇 |
2007年 | 5690篇 |
2006年 | 5309篇 |
2005年 | 5185篇 |
2004年 | 5366篇 |
2003年 | 5109篇 |
2002年 | 5111篇 |
2001年 | 3816篇 |
2000年 | 3722篇 |
1999年 | 3053篇 |
1998年 | 1238篇 |
1997年 | 995篇 |
1996年 | 871篇 |
1995年 | 846篇 |
1994年 | 745篇 |
1993年 | 713篇 |
1992年 | 1818篇 |
1991年 | 1785篇 |
1990年 | 1527篇 |
1989年 | 1467篇 |
1988年 | 1354篇 |
1987年 | 1216篇 |
1986年 | 1205篇 |
1985年 | 1056篇 |
1984年 | 787篇 |
1983年 | 706篇 |
1982年 | 477篇 |
1981年 | 408篇 |
1979年 | 581篇 |
1978年 | 429篇 |
1975年 | 442篇 |
1974年 | 493篇 |
1973年 | 467篇 |
1972年 | 428篇 |
1971年 | 402篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
92.
Céline Chipoy Martine Berreur Séverine Couillaud Gilbert Pradal Fran?ois Vallette Caroline Colombeix Fran?oise Rédini Dominique Heymann Frédéric Blanchard 《Journal of bone and mineral research》2004,19(11):1850-1861
The effects of OSM on proliferation and differentiation of osteosarcoma and nontransformed osteoblasts were analyzed. OSM downregulates osteoblast markers but induces the glial fibrillary acidic protein by the combined activation of PKCdelta and STAT3, offering new lines of therapeutic investigations. INTRODUCTION: Oncostatin M (OSM) is a multifunctional cytokine of the interleukin-6 family implicated in embryonic development, differentiation, inflammation, and regeneration of various tissues, mainly the liver, bone, and the central nervous and hematopoietic systems. One particularity of OSM relies on its growth inhibitory and pro-differentiating effects on a variety of tumor cell lines such as melanoma, providing arguments for a therapeutic application of OSM. The objective of this study was to analyze the effects of OSM on osteosarcoma cell lines proliferation and differentiation. MATERIALS AND METHODS: Proliferation was analyzed by 3H thymidine incorporation. Differentiation was analyzed by semiquantitative RT-PCR and immunocytochemistry for various markers. Alizarin red S staining was used to evaluate bone nodule formation. Morphological changes were studied by confocal and electron microscopy. Western blotting, kinases inhibitors, and dominant negative STAT3 were used to identified the signaling pathways implicated. RESULTS: OSM inhibits the growth of rat osteosarcoma cell lines as well as normal osteoblasts, in correlation with induction of the cyclin-dependent kinases inhibitor p21WAF1. However, OSM reduces osteoblast markers such as alkaline phosphatase, osteocalcin, and bone sialoprotein, leading to strong inhibition of mineralized nodule formation. This inhibitory effect is restricted to mature osteoblasts and differentiated osteosarcoma because OSM effectively stimulates osteoblast markers and bone nodule formation in early, but not late, bone marrow mesenchymal stem cell (BMSC) cultures. In osteosarcoma cells or BMSC, OSM induces expression of the glial fibrillary acidic protein (GFAP) as well as morphological and ultrastructural changes, for example, elongated shape and bundles of microfilaments in cell processes. Rottlerin (PKCdelta inhibitor), and to a lesser degree UO126 (MEK/ERK inhibitor), prevents the loss of osteoblastic markers by OSM, whereas dominant negative STAT3 prevents GFAP induction. CONCLUSIONS: These results highlight the particular gene expression profile of OSM-treated osteosarcoma cells and BMSCs, suggesting either a osteocytic or a glial-like phenotype. Together with the implication of PKCdelta, ERK1/2, and STAT3, these results offer new lines of investigations for neural cell transplantation and osteosarcoma therapy. 相似文献
93.
94.
95.
Dipyridamole and RA-642 inhibit the production of superoxide anion and free radical damage to rat lens. 总被引:1,自引:0,他引:1
J P De la Cruz A Sintas A Moreno J Garcia-Campos F Sanchez de la Cuesta 《Pharmacology & toxicology》1991,69(3):201-204
We studied the effects of dipyridamole and RA-642 on the production of superoxide anions and on oxygen radicals-induced lipid peroxidation in lens tissue homogenates from normal rats and rats given dipyridamole or RA-642 intraperitoneally. Superoxide production was evaluated by phenazine methosulphate (PMS)-induced nitroblue tetrazolium (NBT) reduction and lipid peroxidation by ferrous sulfate and ascorbic acid (FeAs)-induced malondialdehyde (MDA) production. Dipyridamole and RA-642 showed an inhibitory effect on both assays in the experiments with lens tissue homogenates from untreated or treated rats. The extent of inhibition, however, was significantly higher in pyrimidopyrimidinic-treated rats (range of inhibition at different times of incubation was 18% versus 23-57% for dipyridamole and 14% versus 73-80% for RA-642 in the assay of MDA production, and 10% versus 33-37% for dipyridamole and 2.5% versus 11-32% for RA-642 in the assay of NBT reduction). Concentrations of dipyridamole and RA-642 in lens tissue from treated animals could not be determined (less than 0.001 micrograms/mg of tissue). Although both compounds inhibited lipid peroxidation induced by oxygen free radicals, the mechanism of action might include the role of adenosine as a mediator. 相似文献
96.
Contributions of ovarian failure and aging to blood pressure in normotensive perimenopausal women: a mixed longitudinal study 总被引:1,自引:0,他引:1
Epidemiologic studies have shown that blood pressure increases more rapidly in middle-aged women than in middle-aged men. Whether or not ovarian failure contributes to this rapid rise is still not clear. In a follow-up study begun in 1979 and to continue for 10 years, the blood pressure of 193 healthy normotensive perimenopausal women, who lived in the mixed rural/industrial community of Ede, the Netherlands and who were initially aged between 49 and 56 years, was measured annually. During the course of the study, the onset of menopause of each participant could be established. Because of the mixed longitudinal design of the study, it was possible to evaluate the effects of both chronologic aging and time pre- or postmenopause on blood pressure. After the first seven years of follow-up, it was demonstrated that blood pressure did not increase in 168 women whose body weight was relatively stable. After multivariate analyses, systolic as well as diastolic pressure showed a significant negative relation (slope, 1.34 mmHg per year and 0.63 mmHg per year, respectively) with the years since menopause. On the other hand, the observed positive relation (slope, 0.81 mmHg per year) of systolic pressure with chronologic aging was not significant. No consistent association was found between diastolic pressure and chronologic aging. It is concluded that menopause cannot be regarded as a cause of hypertension; on the contrary, ovarian failure appears to have a protective effect on the increase in blood pressure as a result of chronologic aging. on the increase in blood pressure as a result of chronologic aging. 相似文献
97.
98.
99.
Maria Hortal Miguel Estevan Ines Iraola Bremen De Mucio 《International journal of infectious diseases》2007,11(3):273-277
BACKGROUND: Population-based studies on childhood community-acquired pneumonia are scarce in Latin America. Pneumococcal epidemiology is poorly defined, hence the World Health Organization recommended standardized chest radiograph interpretation to improve the approach to bacterial pneumonia. Therefore, our study aimed to estimate the burden of pneumonia in hospitalized children. METHODS: A three-year surveillance study was carried out in four hospitals covering a population of 229,128 inhabitants of whom 10.2% were under five years of age. Clinical records and digitization of their chest radiographs were obtained. A pediatrician and a pediatric radiologist blinded to the clinical diagnosis interpreted the digital images. RESULTS: Of 2034 patients, 826 (40.6%) had consolidated pneumonia, 941 (46.3%) had non-consolidated pneumonia, and 267 (13.1%) had no pneumonia. Children under two years of age predominated (66.9%). The average annual incidence rate for consolidated pneumonia over the three-year study period was 1175/10(5). Eighteen invasive Streptococcus pneumoniae were isolated from patients with consolidated pneumonia and two from those with non-consolidated pneumonia. Respiratory syncytial virus was evenly distributed between both X-ray groups. CONCLUSIONS: Patients younger than two years of age predominated, being the main targets for anti-pneumococcal conjugated vaccines. Incidence rates provided evidence of the burden of consolidated pneumonia for childhood, estimating the potential benefits of vaccination. 相似文献
100.